Dapagliflozin Safe and Effective in Elderly Patients with Heart Failure Undergoing Valve Replacement
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve ...
An artificial intelligence (AI) model trained to detect blocked coronary arteries based on electrocardiogram (ECG) readings performed better than ...
People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to ...
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery ...
An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years in women ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients ...
Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in ...
At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood ...
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least ...
In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was ...
AI is changing the way we work, create, and share information — but brownies? A new study from the University of Illinois ...
According to a recent study at the University of Jyväskylä, Finland, the impacts of everyday physical activity do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results